Skip to content
Live newsroom 133 readers online
Friday, September 4, 2026 Live Sync: Just now
Trending:
Nifty 50 BSE Sensex Indian Auto AI & Tech F1 Racing Share suggestions Crypto & Commodities
BreakingI'm skipping the physical media craze and turning my old Android phone into a FLAC player instead
Important AVOID INFY Stage 4 (Conv: 1/5 | Size: 10%)

Gland Pharma block deal: Fosun Pharma divests 99 lakh shares worth Rs 2,800 crore

Fosun Pharma sold a 6% stake in Gland Pharma for ₹2,800 crore, reducing its holding to about 45.77%. Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, […]

By deepak · September 4, 2026 · 1 min read

Fosun Pharma sold a 6% stake in Gland Pharma for ₹2,800 crore, reducing its holding to about 45.77%.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Season of change in accounting policy: A simple AI prompt can tell you a lot

Is crude oil becoming a financial problem?

Patent Cliff approaching: Can Indian pharma companies repeat past success?

Q1 investment numbers look stellar, but are we celebrating too early?

ET Prime special: Bigger, Better or Both? Understanding business to figure out the mystery: Power Grid Corp – Part 1

ET Prime special series: 2013 to 2026. Not years, but evidence: Power Grid, Part 2

Source: Read the original article on economictimes.indiatimes.com

Related Coverage

Trump’s Venezuelan Oil Deal Relies on a Powerful and Divisive Partner

August 30, 2026

When does the January transfer window open?

September 1, 2026

Jury begins to deliberate after closing statements in Lindsay Clancy trial

August 28, 2026

Important Legal & Financial Disclaimer

FutureKnowledge is an automated financial intelligence aggregator. The information provided on this website does not constitute investment advice, financial advice, trading advice, or any other sort of advice and you should not treat any of the website's content as such. We are not registered with the SEC, SEBI, or any regulatory agency. Automated AI-generated content may contain errors. Always conduct your own due diligence and consult your financial advisor before making any investment decisions.

© 2026 FutureKnowledge Intelligence. All rights reserved.